4//SEC Filing
Kramer Kelly A. 4
Accession 0001127602-25-013772
CIK 0000882095other
Filed
May 7, 8:00 PM ET
Accepted
May 8, 8:17 PM ET
Size
7.5 KB
Accession
0001127602-25-013772
Insider Transaction Report
Form 4
Kramer Kelly A.
Director
Transactions
- Award
Restricted Stock Unit
2025-05-07+1,516→ 19,110 total→ Common Stock (1,516 underlying) - Award
Non-qualified Stock Option (Right to Buy)
2025-05-07+6,809→ 6,809 totalExercise: $98.90Exp: 2035-05-07→ Common Stock (6,809 underlying)
Footnotes (3)
- [F1]Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
- [F2]100% of the restricted stock units vested immediately upon the grant date of May 7, 2025.
- [F3]100% of the shares subject to the stock option vested immediately upon the grant date of May 7, 2025.
Documents
Issuer
GILEAD SCIENCES, INC.
CIK 0000882095
Entity typeother
Related Parties
1- filerCIK 0001629885
Filing Metadata
- Form type
- 4
- Filed
- May 7, 8:00 PM ET
- Accepted
- May 8, 8:17 PM ET
- Size
- 7.5 KB